Overview

Lacosamide in Neonatal Status Epilepticus

Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
Lacosamide in neonatal status epilepticus
Phase:
Phase 3
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Lacosamide
Phenobarbital